Treatment of perimenstrual migraine with triptans: an update.
Pure menstrual migraine (PMM) and menstrually related migraine (MRM) are difficult challenges in migraine management. Triptans are a class of highly selective serotonin receptor agonists, which interfere with the pathogenesis of migraine and are effective in relieving the associated neurovegetative symptoms. In recent years triptans have been extensively proposed for the treatment of severe, disabling, and recurrent perimenstrual migraine attacks. This review summarizes the different levels of recommendations for the use of triptans in the treatment of perimenstrual migraine. This review is also intended to offer an updated reasonable guide to physicians treating perimenstrual migraine in daily practice.
Sapienza University, Advanced Molecular Diagnostic Unit, NESMOS Department, Sant'Andrea Hospital, Rome, Italy.
Barbara
B
Casolla
Luana
L
Lionetto
Serena
S
Candela
Lidia
L
D'Alonzo
Andrea
A
Negro
Maurizio
M
Simmaco
Paolo
P
Martelletti
D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D011293:Premenstrual Syndrome / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D016032:Randomized Controlled Trials as Topic / Q000379:methods / Q000639:trends; D018170:Sumatriptan / Q000627:therapeutic use; D016896:Treatment Outcome; D014363:Tryptamines / Q000627:therapeutic use*
D014363:Tryptamines; C409045:almotriptan; D018170:Sumatriptan